INS and metabolic syndrome: Traditionally, laboratory diagnoses of MetS and assessments of CVD risk include analyses of blood (serum or plasma) biomarkers, i.e., total cholesterol (TC), TG, HDL-C, low-density lipoprotein cholesterol (LDL-C), insulin and C-peptide [18].